MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The FBI Jan. 8 released an alert on evolving threat tactics by Kimsuky, a North Korean state-sponsored cyber threat group. As of last year, the group…
Headline
The House Jan. 8 passed legislation granting a three-year extension of the enhanced premium tax credits, which the federal government offers to help some…
Headline
The AHA Jan. 9 urged the Medicare Payment Advisory Commission to consider, during its next meeting Jan. 15-16, higher payment updates for the…
Headline
A study published Jan. 7 by the University of Minnesota Rural Health Research Center examined the availability of hospital-based obstetric services in the U.S…
Headline
An AHA blog published Jan. 8 highlights an EY analysis prepared for the AHA on the ways nonprofit hospitals and health systems contribute to their…
Perspective
Congress returned to Washington this week with a full plate of issues to contend with in the short-term as it defines its legislative agenda for the remainder…